Biogen Inc. (BIIB)
NASDAQ
225.71
+7.28 (+3.33%)
Closed
Oct 9, 2026
Day's Range
219.23227.20
52 wk Range
138.00230.49
Financial Statements - BIIB - Biogen Inc.
Revenue
9.89B▲ 2.2%
Net Income
1.29B▼ 20.8%Net Margin 13.1%
EBITDA
3.39B▲ 12.6%
Free Cash Flow
1.96B▼ 21.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 9.89B | 9.67B | 9.83B | 10.17B | 10.98B | 13.44B |
| Cost of Goods | 2.40B | 2.31B | 2.53B | 2.27B | 2.10B | 1.80B |
| Gross Profit | 7.48B | 7.36B | 7.30B | 7.89B | 8.87B | 11.63B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 2.46B | 2.21B | 1.83B | 2.90B | 2.80B | 4.44B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -770M | -130.20M | -563.90M | 847.20M | -820.20M | 781.70M |
| Pre Tax Income | 1.55B | 1.90B | 1.29B | 3.59B | 1.74B | 5.04B |
| Income Tax | 263.60M | 273.80M | 135.30M | 632.80M | 52.50M | 992.30M |
| Net Income | 1.29B | 1.63B | 1.16B | 2.96B | 1.72B | 4.06B |
| EPS Basic | 8.83 | 11.21 | 8.02 | 20.96 | 10.44 | 24.86 |
| EPS Diluted | 8.79 | 11.18 | 7.97 | 20.87 | 10.4 | 24.8 |
| Basic Shares Outstanding | 146.50M | 145.60M | 144.70M | 145.30M | 149.10M | 160.90M |
| Diluted Shares Outstanding | 146.50M | 145.60M | 144.70M | 145.30M | 149.10M | 160.90M |
| Ebit | 1.82B | 2.15B | 1.54B | 3.83B | 1.99B | 5.27B |
| Ebitda | 3.39B | 3.01B | 2.59B | 3.49B | 3.69B | 4.95B |
| Net Income Continuous Operations | 1.29B | 1.63B | 1.16B | 2.96B | 1.72B | 4.06B |
| Minority Interests | 0 | 0 | -400K | 85.30M | -171.50M | -59.90M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
